Suppr超能文献

微小RNA对癌细胞线粒体功能、代谢重编程及化疗耐药性的作用与影响:一项系统综述

MiRNAs Action and Impact on Mitochondria Function, Metabolic Reprogramming and Chemoresistance of Cancer Cells: A Systematic Review.

作者信息

Rosolen Daiane, Nunes-Souza Emanuelle, Marchi Rafael, Tofolo Maria Vitoria, Antunes Valquíria C, Berti Fernanda C B, Fonseca Aline S, Cavalli Luciane R

机构信息

Research Institute Pelé Pequeno Príncipe, Faculdades Pequeno Príncipe, Curitiba 80230-020, PR, Brazil.

Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, WA 20057, USA.

出版信息

Biomedicines. 2023 Feb 24;11(3):693. doi: 10.3390/biomedicines11030693.

Abstract

MicroRNAs (miRNAs) are involved in the regulation of mitochondrial function and homeostasis, and in the modulation of cell metabolism, by targeting known oncogenes and tumor suppressor genes of metabolic-related signaling pathways involved in the hallmarks of cancer. This systematic review focuses on articles describing the role, association, and/or involvement of miRNAs in regulating the mitochondrial function and metabolic reprogramming of cancer cells. Following the PRISMA guidelines, the articles reviewed were published from January 2010 to September 2022, with the search terms "mitochondrial microRNA" and its synonyms (mitochondrial microRNA, mitochondrial miRNA, mito microRNA, or mitomiR), "reprogramming metabolism," and "cancer" in the title or abstract). Thirty-six original research articles were selected, revealing 51 miRNAs with altered expression in 12 cancers: bladder, breast, cervical, colon, colorectal, liver, lung, melanoma, osteosarcoma, pancreatic, prostate, and tongue. The actions of miRNAs and their corresponding target genes have been reported mainly in cell metabolic processes, mitochondrial dynamics, mitophagy, apoptosis, redox signaling, and resistance to chemotherapeutic agents. Altogether, these studies support the role of miRNAs in the metabolic reprogramming hallmark of cancer cells and highlight their potential as predictive molecular markers of treatment response and/or targets that can be used for therapeutic intervention.

摘要

微小RNA(miRNA)通过靶向参与癌症特征的代谢相关信号通路的已知癌基因和肿瘤抑制基因,参与线粒体功能和稳态的调节以及细胞代谢的调控。本系统综述聚焦于描述miRNA在调节癌细胞线粒体功能和代谢重编程中的作用、关联和/或参与情况的文章。按照PRISMA指南,所综述的文章发表于2010年1月至2022年9月,检索词为标题或摘要中包含“线粒体微小RNA”及其同义词(线粒体微小RNA、线粒体miRNA、线粒体小RNA或线粒体miR)、“代谢重编程”和“癌症”。共筛选出36篇原创研究文章,发现12种癌症(膀胱癌、乳腺癌、宫颈癌、结肠癌、结直肠癌、肝癌、肺癌、黑色素瘤、骨肉瘤、胰腺癌、前列腺癌和舌癌)中有51种miRNA表达改变。miRNA及其相应靶基因的作用主要在细胞代谢过程、线粒体动力学、线粒体自噬、细胞凋亡、氧化还原信号传导以及对化疗药物的抗性方面有报道。总之,这些研究支持了miRNA在癌细胞代谢重编程特征中的作用,并突出了它们作为治疗反应预测分子标志物和/或可用于治疗干预的靶点的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/235e/10045760/6a4b6e4ac6fd/biomedicines-11-00693-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验